| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-05 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-05 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |